Latin American and Caribbean consensus on noninvasive central nervous system neuromodulation for chronic pain management (LAC2-NIN-CP)

Autor: Durval Campos Kraychete, Fabian Piedimonte, Kátia Monte-Silva, Manuel Sempértegui Gallegos, Elias Atencio, Jean Pascal Lefaucheur, João Batista Santos Garcia, Lucy S. Chipchase, Patricia Bonilla, Luis C. L. Correia, Katia Nunes Sá, Aziza Jreige Iskandar, Valquíria Aparecida da Silva, Abrahão Fontes Baptista, Fuad Ahmed Hazime, María Del Rosario Berenguel Cook, Ricardo Galhardoni, José Alberto Flores Cantisani, Marco Antonio Marcolin, Ana Mércia Fernandes, Andre R. Brunoni, Alexandre Hideki Okano, Manoel Jacobsen Teixeira, Frantz Colimon, John Jairo Hernández-Castro, Daniel Ciampi de Andrade, Wolnei Caumo, William Delgado Barrera, César Amescua-García, Didier Bouhassira, Argelia Lara-Solares, Pedro Schestatsky, María Antonieta Ricco, Egas M. Caparelli-Dáquer, Carlos Guerrero
Jazyk: angličtina
Rok vydání: 2019
Předmět:
Zdroj: Pain Reports
PAIN Reports, Vol 4, Iss 1, p e692 (2019)
ISSN: 2471-2531
Popis: Supplemental Digital Content is Available in the Text.
Introduction: Chronic pain (CP) is highly prevalent and generally undertreated health condition. Noninvasive brain stimulation may contribute to decrease pain intensity and influence other aspects related to CP. Objective: To provide consensus-based recommendations for the use of noninvasive brain stimulation in clinical practice. Methods: Systematic review of the literature searching for randomized clinical trials followed by consensus panel. Recommendations also involved a cost-estimation study. Results: The systematic review wielded 24 transcranial direct current stimulation (tDCS) and 22 repetitive transcranial magnetic stimulation (rTMS) studies. The following recommendations were provided: (1) Level A for anodal tDCS over the primary motor cortex (M1) in fibromyalgia, and level B for peripheral neuropathic pain, abdominal pain, and migraine; bifrontal (F3/F4) tDCS and M1 high-definition (HD)-tDCS for fibromyalgia; Oz/Cz tDCS for migraine and for secondary benefits such as improvement in quality of life, decrease in anxiety, and increase in pressure pain threshold; (2) level A recommendation for high-frequency (HF) rTMS over M1 for fibromyalgia and neuropathic pain, and level B for myofascial or musculoskeletal pain, complex regional pain syndrome, and migraine; (3) level A recommendation against the use of anodal M1 tDCS for low back pain; and (4) level B recommendation against the use of HF rTMS over the left dorsolateral prefrontal cortex in the control of pain. Conclusion: Transcranial DCS and rTMS are recommended techniques to be used in the control of CP conditions, with low to moderate analgesic effects, and no severe adverse events. These recommendations are based on a systematic review of the literature and a consensus made by experts in the field. Readers should use it as part of the resources available to decision-making.
Databáze: OpenAIRE